Clinical Trial: Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treament: A Pilot Trial

The primary aim of this study is to assess the feasibility of long-acting injectable naltrexone provided through primary care (LAN/PC) versus long-acting injectable naltrexone in the specialized chemical dependence clinic (LAN/CDC). The secondary aim is to obtain preliminary assessments of the relative effectiveness of long-acting injectable naltrexone in primary care versus in the chemical dependence clinic.

This study is currently recruiting patients.
Verified by State University of New York - Upstate Medical University March 2007

Sponsors and Collaborators:	State University of New York - Upstate Medical University Department of Veterans Affairs
Information provided by:	State University of New York - Upstate Medical University

READ FULL STUDY ANNOUNCEMENT
________________________________________________________________